<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37429644</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1757-790X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>10</Day></PubDate></JournalIssue><Title>BMJ case reports</Title><ISOAbbreviation>BMJ Case Rep</ISOAbbreviation></Journal><ArticleTitle>Secondary haemophagocytic lymphohistiocytosis in a patient with new-onset systemic lupus erythematosus: the challenges of timely diagnosis and successful treatment.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e252938</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2022-252938</ELocationID><Abstract><AbstractText>Haemophagocytic lymphohistiocytosis (HLH) is an immune-mediated disease driven by abnormal macrophage activation and regulatory cell dysfunction. HLH can be primary due to genetic mutations or secondary due to infection, malignancy or autoimmune conditions. We describe a woman in her early 30s who developed HLH while being treated for newly diagnosed systemic lupus erythematosus (SLE) complicated by lupus nephritis as well as concomitant cytomegalovirus (CMV) reactivation from a dormant infection. The trigger for this secondary form of HLH may have been either aggressive SLE and/or CMV reactivation. Despite prompt treatment with immunosuppressive therapies for SLE consisting of high-dose corticosteroids, mycophenolate mofetil, tacrolimus, etoposide for HLH and ganciclovir for CMV infection, the patient developed multiorgan failure and passed away. We demonstrate the difficulty in identifying a specific cause for secondary HLH when multiple conditions are present (SLE and CMV) and the fact that, despite aggressive treatment for both conditions, the mortality for HLH remains high.</AbstractText><CopyrightInformation>&#xa9; BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Daming</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Medicine, Jacobi Medical Center, Bronx, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pena</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Medicine, Jacobi Medical Center, Bronx, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekulic</LastName><ForeName>Miroslav</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdez Imbert</LastName><ForeName>Ronald</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Medicine, Jacobi Medical Center, Bronx, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vegivinti</LastName><ForeName>Charan Thej Reddy</ForeName><Initials>CTR</Initials><AffiliationInfo><Affiliation>Medicine, Jacobi Medical Center, Bronx, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jim</LastName><ForeName>Belinda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medicine, Jacobi Medical Center, Bronx, New York, USA belindajim286@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Case Rep</MedlineTA><NlmUniqueID>101526291</NlmUniqueID><ISSNLinking>1757-790X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051359" MajorTopicYN="Y">Lymphohistiocytosis, Hemophagocytic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003586" MajorTopicYN="Y">Cytomegalovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute renal failure</Keyword><Keyword MajorTopicYN="N">Immunology</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>11</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37429644</ArticleId><ArticleId IdType="pmc">PMC10335589</ArticleId><ArticleId IdType="doi">10.1136/bcr-2022-252938</ArticleId><ArticleId IdType="pii">16/7/e252938</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant 2010;16(1 Suppl):S82&#x2013;9. 10.1016/j.bbmt.2009.11.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbmt.2009.11.014</ArticleId><ArticleId IdType="pubmed">19932759</ArticleId></ArticleIdList></Reference><Reference><Citation>Egeler RM, Shapiro R, Loechelt B, et al. . Characteristic immune abnormalities in Hemophagocytic Lymphohistiocytosis. J Pediatr Hematol Oncol 1996;18:340&#x2013;5. 10.1097/00043426-199611000-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00043426-199611000-00002</ArticleId><ArticleId IdType="pubmed">8888739</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii E, Ueda I, Shirakawa R, et al. . Genetic subtypes of familial Hemophagocytic Lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood 2005;105:3442&#x2013;8. 10.1182/blood-2004-08-3296</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2004-08-3296</ArticleId><ArticleId IdType="pubmed">15632205</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepp SE, Dufourcq-Lagelouse R, Le Deist F, et al. . Perforin gene defects in familial Hemophagocytic Lymphohistiocytosis. Science 1999;286:1957&#x2013;9. 10.1126/science.286.5446.1957</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.286.5446.1957</ArticleId><ArticleId IdType="pubmed">10583959</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, et al. . European League against rheumatism/American college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol 2019;71:1400&#x2013;12. 10.1002/art.40930</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40930</ArticleId><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hines MR, von Bahr Greenwood T, Beutel G, et al. . Consensus-Based guidelines for the recognition, diagnosis, and management of hemophagocytic lymphohistiocytosis in critically ill children and adults. Crit Care Med 2022;50:860&#x2013;72. 10.1097/CCM.0000000000005361</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005361</ArticleId><ArticleId IdType="pubmed">34605776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt NS, Oshrine B, An Talano J. Hemophagocytic lymphohistiocytosis in adults. Leuk Lymphoma 2019;60:19&#x2013;28. 10.1080/10428194.2018.1482543</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10428194.2018.1482543</ArticleId><ArticleId IdType="pubmed">29966474</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter SJ, Tattersall RS, Ramanan AV. Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment. Rheumatology (Oxford) 2019;58:5&#x2013;17. 10.1093/rheumatology/key006</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/key006</ArticleId><ArticleId IdType="pubmed">29481673</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H, Tsuboi H, Kurata I, et al. . Predictors of the response to treatment in acute lupus Hemophagocytic syndrome. Lupus 2015;24:659&#x2013;68. 10.1177/0961203314559086</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314559086</ArticleId><ArticleId IdType="pubmed">25391543</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong KF, Hui PK, Chan JK, et al. . The acute lupus Hemophagocytic syndrome. Ann Intern Med 1991;114:387&#x2013;90. 10.7326/0003-4819-114-5-387</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-114-5-387</ArticleId><ArticleId IdType="pubmed">1992881</ArticleId></ArticleIdList></Reference><Reference><Citation>Henter J-I, Horne A, Aric&#xf3; M, et al. . HLH-2004: diagnostic and therapeutic guidelines for Hemophagocytic Lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124&#x2013;31. 10.1002/pbc.21039</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pbc.21039</ArticleId><ArticleId IdType="pubmed">16937360</ArticleId></ArticleIdList></Reference><Reference><Citation>Parodi A, Dav&#xec; S, Pringe AB, et al. . Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum 2009;60:3388&#x2013;99. 10.1002/art.24883</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.24883</ArticleId><ArticleId IdType="pubmed">19877067</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz A, Castaneda EE, Ahmad N, et al. . Exploring macrophage activation syndrome secondary to systemic lupus erythematosus in adults: A systematic review of the literature. Cureus 2021;13:e18822. 10.7759/cureus.18822</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18822</ArticleId><ArticleId IdType="pmc">PMC8592789</ArticleId><ArticleId IdType="pubmed">34804679</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdirakhmanova A, Sazonov V, Mukusheva Z, et al. . Macrophage activation syndrome in pediatric systemic lupus erythematosus: A systematic review of the diagnostic aspects. Front Med (Lausanne) 2021;8:681875. 10.3389/fmed.2021.681875</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.681875</ArticleId><ArticleId IdType="pmc">PMC8211727</ArticleId><ArticleId IdType="pubmed">34150813</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L-W, Wei JC-C, Chen D-Y, et al. . Bidirectional association between systemic lupus erythematosus and macrophage activation syndrome: a nationwide population-based study. Rheumatology (Oxford) 2022;61:1123&#x2013;32. 10.1093/rheumatology/keab502</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab502</ArticleId><ArticleId IdType="pubmed">34146089</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#x2019;Guyen Y, Baumard S, Salmon JH, et al. . Cytomegalovirus associated Hemophagocytic Lymphohistiocytosis in patients suffering from Crohn&#x2019;s disease treated by azathioprine: a series of four cases. Inflamm Bowel Dis 2011;17:E116&#x2013;8. 10.1002/ibd.21770</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ibd.21770</ArticleId><ArticleId IdType="pubmed">21710533</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergmann K, M&#xf8;ller HEH, Bergmann OJ. Cytomegalovirus-associated Haemophagocytic Lymphohistiocytosis: a rare cause of febrile neutropenia during cancer chemotherapy. BMJ Case Rep 2018. 10.1136/bcr-2018-225592</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2018-225592</ArticleId><ArticleId IdType="pmc">PMC6144260</ArticleId><ArticleId IdType="pubmed">30217800</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukaya S, Yasuda S, Hashimoto T, et al. . Clinical features of Haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) 2008;47:1686&#x2013;91. 10.1093/rheumatology/ken342</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken342</ArticleId><ArticleId IdType="pubmed">18782855</ArticleId></ArticleIdList></Reference><Reference><Citation>Sijpkens YW, Allaart CF, Thompson J, et al. . Fever and progressive pancytopenia in a 20-year-old woman with Crohn&#x2019;s disease. Ann Hematol 1996;72:286&#x2013;90. 10.1007/s002770050174</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002770050174</ArticleId><ArticleId IdType="pubmed">8624386</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolsdorph L&#xc5;, Mosevoll KA, Helgeland L, et al. . Concomitant Hemophagocytic Lymphohistiocytosis and cytomegalovirus disease: A case based systemic review. Front Med (Lausanne) 2022;9:819465. 10.3389/fmed.2022.819465</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.819465</ArticleId><ArticleId IdType="pmc">PMC9063453</ArticleId><ArticleId IdType="pubmed">35514747</ArticleId></ArticleIdList></Reference><Reference><Citation>Atim-Oluk M. Cytomegalovirus associated haemophagocytic lymphohistiocytosis in the immunocompetent adult managed according to HLH-2004 diagnostic using clinical and serological means only. Eur J Microbiol Immunol 2013;3:81&#x2013;9. 10.1556/EuJMI.3.2013.1.12</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/EuJMI.3.2013.1.12</ArticleId><ArticleId IdType="pmc">PMC3832083</ArticleId><ArticleId IdType="pubmed">24265923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonnecaze AK, Willeford WG, Lichstein P. Acute cytomegalovirus (CMV) infection associated with hemophagocytic lymphohistiocytosis (hLH). Cureus 2017;9:e1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5376153</ArticleId><ArticleId IdType="pubmed">28409071</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon CM, Jung YW, Yun DY, et al. . A case of acute Pericarditis with Hemophagocytic syndrome, cytomegalovirus infection and systemic lupus erythematosus. Rheumatol Int 2008;28:271&#x2013;3. 10.1007/s00296-007-0401-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-007-0401-y</ArticleId><ArticleId IdType="pubmed">17624532</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta E, Bowlin T, Brooks J, et al. . Advances in the development of Therapeutics for cytomegalovirus infections. J Infect Dis 2020;221(Suppl 1):S32&#x2013;44. 10.1093/infdis/jiz493</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiz493</ArticleId><ArticleId IdType="pmc">PMC7057787</ArticleId><ArticleId IdType="pubmed">32134483</ArticleId></ArticleIdList></Reference><Reference><Citation>Divithotawela C, Garrett P, Westall G, et al. . Successful treatment of cytomegalovirus associated Hemophagocytic Lymphohistiocytosis with the interleukin 1 inhibitor - Anakinra. Respirol Case Rep 2016;4:4&#x2013;6. 10.1002/rcr2.137</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rcr2.137</ArticleId><ArticleId IdType="pmc">PMC4722096</ArticleId><ArticleId IdType="pubmed">26839691</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau A, Youn H, Caricchio R, et al. . A case of cytomegalovirus-induced hemophagocytic lymphohistiocytosis in a patient with an underlying rheumatic disease. Cureus 2020;12:e8130. 10.7759/cureus.8130</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.8130</ArticleId><ArticleId IdType="pmc">PMC7294891</ArticleId><ArticleId IdType="pubmed">32550050</ArticleId></ArticleIdList></Reference><Reference><Citation>Arico M, JI, Egeler RM, et al. . HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH Study group of the histiocyte Society. Med Pediatr Oncol 1997;28:342&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9121398</ArticleId></ArticleIdList></Reference><Reference><Citation>Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol 2010;22:561&#x2013;6. 10.1097/01.bor.0000381996.69261.71</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.bor.0000381996.69261.71</ArticleId><ArticleId IdType="pmc">PMC4443835</ArticleId><ArticleId IdType="pubmed">20517154</ArticleId></ArticleIdList></Reference><Reference><Citation>Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol 2016;12:259&#x2013;68. 10.1038/nrrheum.2015.179</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2015.179</ArticleId><ArticleId IdType="pmc">PMC5851441</ArticleId><ArticleId IdType="pubmed">27009539</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf6;nmez HE, Demir S, Bilginer Y, et al. . Anakinra treatment in macrophage activation syndrome: a single center experience and systemic review of literature. Clin Rheumatol 2018;37:3329&#x2013;35. 10.1007/s10067-018-4095-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4095-1</ArticleId><ArticleId IdType="pubmed">29663156</ArticleId></ArticleIdList></Reference><Reference><Citation>Phadke O, Rouster-Stevens K, Giannopoulos H, et al. . Intravenous administration of Anakinra in children with macrophage activation syndrome. Pediatr Rheumatol 2021;19. 10.1186/s12969-021-00585-310.1186/s12969-021-00585-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-021-00585-3</ArticleId><ArticleId IdType="doi">10.1186/s12969-021-00585-3</ArticleId><ArticleId IdType="pmc">PMC8240425</ArticleId><ArticleId IdType="pubmed">34187503</ArticleId></ArticleIdList></Reference><Reference><Citation>Eloseily EM, Weiser P, Crayne CB, et al. . Benefit of Anakinra in treating pediatric secondary Hemophagocytic Lymphohistiocytosis. Arthritis Rheumatol 2020;72:326&#x2013;34. 10.1002/art.41103</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41103</ArticleId><ArticleId IdType="pubmed">31513353</ArticleId></ArticleIdList></Reference><Reference><Citation>Le RQ, Li L, Yuan W, et al. . FDA approval summary: Tocilizumab for treatment of Chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome. Oncologist 2018;23:943&#x2013;7. 10.1634/theoncologist.2018-0028</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2018-0028</ArticleId><ArticleId IdType="pmc">PMC6156173</ArticleId><ArticleId IdType="pubmed">29622697</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufranc E, Del Bello A, Belliere J, et al. . Il6-R blocking with Tocilizumab in critically ill patients with Hemophagocytic syndrome. Crit Care 2020;24:166. 10.1186/s13054-020-02878-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02878-7</ArticleId><ArticleId IdType="pmc">PMC7175448</ArticleId><ArticleId IdType="pubmed">32321563</ArticleId></ArticleIdList></Reference><Reference><Citation>De Benedetti F, Brunner HI, Ruperto N, et al. . Randomized trial of Tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 2012;367:2385&#x2013;95. 10.1056/NEJMoa1112802</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1112802</ArticleId><ArticleId IdType="pubmed">23252525</ArticleId></ArticleIdList></Reference><Reference><Citation>Keenan C, Nichols KE, Albeituni S. Use of the JAK inhibitor Ruxolitinib in the treatment of Hemophagocytic Lymphohistiocytosis. Front Immunol 2021;12:614704. 10.3389/fimmu.2021.614704</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.614704</ArticleId><ArticleId IdType="pmc">PMC7923355</ArticleId><ArticleId IdType="pubmed">33664745</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Wei A, Ma H-H, et al. . A pilot study of Ruxolitinib as a front-line therapy for 12 children with secondary Hemophagocytic Lymphohistiocytosis. Haematologica 2021;106:1892&#x2013;901. 10.3324/haematol.2020.253781</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2020.253781</ArticleId><ArticleId IdType="pmc">PMC8252948</ArticleId><ArticleId IdType="pubmed">32732367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A, Merrill SA, Alsawah F, et al. . Ruxolitinib in adult patients with secondary Haemophagocytic Lymphohistiocytosis: an open-label, single-centre, pilot trial. Lancet Haematol 2019;6:e630&#x2013;7. 10.1016/S2352-3026(19)30156-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(19)30156-5</ArticleId><ArticleId IdType="pmc">PMC8054981</ArticleId><ArticleId IdType="pubmed">31537486</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen EM, D&#x2019;Silva K, Kreps D, et al. . Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus. Lupus 2018;27:1065&#x2013;71. 10.1177/0961203318759428</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318759428</ArticleId><ArticleId IdType="pmc">PMC5938123</ArticleId><ArticleId IdType="pubmed">29451069</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu A-C, Yang Y, Li M-T, et al. . Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China. Clin Rheumatol 2018;37:93&#x2013;100. 10.1007/s10067-017-3625-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-017-3625-6</ArticleId><ArticleId IdType="pubmed">28409239</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn SS, Yoo B-W, Jung SM, et al. . In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome. Semin Arthritis Rheum 2017;47:216&#x2013;21. 10.1016/j.semarthrit.2017.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2017.02.002</ArticleId><ArticleId IdType="pubmed">28268026</ArticleId></ArticleIdList></Reference><Reference><Citation>Dall'Ara F, Cavazzana I, Frassi M, et al. . Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center. Reumatismo 2018;70:100&#x2013;5. 10.4081/reumatismo.2018.1023</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/reumatismo.2018.1023</ArticleId><ArticleId IdType="pubmed">29976044</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambotte O, Khellaf M, Harmouche H, et al. . Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated Hemophagocytic syndrome. Medicine (Baltimore) 2006;85:169&#x2013;82. 10.1097/01.md.0000224708.62510.d1</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.md.0000224708.62510.d1</ArticleId><ArticleId IdType="pubmed">16721259</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavand P-E, Serio I, Arnaud L, et al. . Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: A study of 103 episodes in 89 adult patients. Autoimmun Rev 2017;16:743&#x2013;9. 10.1016/j.autrev.2017.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2017.05.010</ArticleId><ArticleId IdType="pubmed">28483541</ArticleId></ArticleIdList></Reference><Reference><Citation>Keith MP, Pitchford C, Bernstein WB. Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosus. J Clin Rheumatol 2012;18:134&#x2013;7. 10.1097/RHU.0b013e31824e8d9b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0b013e31824e8d9b</ArticleId><ArticleId IdType="pubmed">22426581</ArticleId></ArticleIdList></Reference><Reference><Citation>Gliwi&#x144;ska A, Bjanid O, Adamczyk P, et al. . A rare complication of systemic lupus erythematosus in a 9-year-old girl: questions. Pediatr Nephrol 2020;35:777&#x2013;9. 10.1007/s00467-019-04411-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-019-04411-7</ArticleId><ArticleId IdType="pmc">PMC7096360</ArticleId><ArticleId IdType="pubmed">31823041</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkoht A, Hanafi I, Khalil B. Macrophage activation syndrome: A report of two cases and a literature review. Case Rep Rheumatol 2017;2017:5304180. 10.1155/2017/5304180</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/5304180</ArticleId><ArticleId IdType="pmc">PMC5676417</ArticleId><ArticleId IdType="pubmed">29209549</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouda W, Alsaqabi F, Moshrif A, et al. . Macrophage activation syndrome triggered by systemic lupus erythematosus flare: successful treatment with a combination of dexamethasone sodium phosphate, intravenous immunoglobulin, and cyclosporine: a case report. J Med Case Rep 2021;15. 10.1186/s13256-021-03072-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-021-03072-1</ArticleId><ArticleId IdType="pmc">PMC8495443</ArticleId><ArticleId IdType="pubmed">34620236</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumakura S, Ishikura H, Kondo M, et al. . Autoimmune-associated hemophagocytic syndrome. Modern Rheumatology 2004;14:205&#x2013;15. 10.3109/s10165-004-0293-6</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/s10165-004-0293-6</ArticleId><ArticleId IdType="pubmed">17143676</ArticleId></ArticleIdList></Reference><Reference><Citation>Pop CS, Becheanu G, Calagiu D, et al. . A rare complication of CMV infection in Crohn's disease - hemophagocytic syndrome: a case report. Rom J Morphol Embryol 2015;56:1535&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">26743306</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez-Camba A, Lakhwani S, Ramos L, et al. . Cytomegalovirus-Associated hemophagocytic syndrome in a patient with Crohn's disease receiving azathioprine. J Gastrointestin Liver Dis 2013;22:471&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">24369333</ArticleId></ArticleIdList></Reference><Reference><Citation>Mun JI, Shin SJ, Yu BH, et al. . A case of Hemophagocytic syndrome in a patient with fulminant ulcerative colitis Superinfected by cytomegalovirus. Korean J Intern Med 2013;28:352&#x2013;5. 10.3904/kjim.2013.28.3.352</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2013.28.3.352</ArticleId><ArticleId IdType="pmc">PMC3654134</ArticleId><ArticleId IdType="pubmed">23682230</ArticleId></ArticleIdList></Reference><Reference><Citation>van Langenberg DR, Morrison G, Foley A, et al. . Cytomegalovirus disease, haemophagocytic syndrome, immunosuppression in patients with IBD: &#x2018;A cocktail best avoided, not stirred&#x2019;. Journal of Crohn's and Colitis 2011;5:469&#x2013;72. 10.1016/j.crohns.2011.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crohns.2011.04.010</ArticleId><ArticleId IdType="pubmed">21939923</ArticleId></ArticleIdList></Reference><Reference><Citation>Presti MAL, Costantino G, Della Torre A, et al. . Severe CMV-related pneumonia complicated by the hemophagocytic lymphohistiocytic (hLH) syndrome in quiescent Crohn's colitis: harmful cure? Inflamm Bowel Dis 2011;17:E145&#x2013;6. 10.1002/ibd.21828</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ibd.21828</ArticleId><ArticleId IdType="pubmed">21826767</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Montoya L, S&#xe1;enz-Tenorio CN, Janta I, et al. . Hemophagocytic Lymphohistiocytosis in a patient with Sjogren&#x2019;s syndrome: case report and review. Rheumatol Int 2017;37:663&#x2013;9. 10.1007/s00296-016-3601-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-016-3601-5</ArticleId><ArticleId IdType="pmc">PMC7102319</ArticleId><ArticleId IdType="pubmed">27853859</ArticleId></ArticleIdList></Reference><Reference><Citation>Amel R, Monia K, Anis M, et al. . Systemic lupus Erythematous revealed by cytomegalovirus infection. Pan Afr Med J 2016;24:241. 10.11604/pamj.2016.24.241.8988</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2016.24.241.8988</ArticleId><ArticleId IdType="pmc">PMC5075437</ArticleId><ArticleId IdType="pubmed">27800096</ArticleId></ArticleIdList></Reference><Reference><Citation>Koketsu S-ichiro, Watanabe T, Hori N, et al. . Hemophagocytic syndrome caused by fulminant ulcerative colitis and cytomegalovirus infection: report of a case. Dis Colon Rectum 2004;47:1250&#x2013;5. 10.1007/s10350-004-0543-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10350-004-0543-x</ArticleId><ArticleId IdType="pubmed">15148644</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto O, Ando M, Yoshimatsu S, et al. . Systemic lupus erythematosus complicated by cytomegalovirus-induced hemophagocytic syndrome and colitis. Intern Med 2002;41:151&#x2013;5. 10.2169/internalmedicine.41.151</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.41.151</ArticleId><ArticleId IdType="pubmed">11868605</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz J, Shareef N, Donthireddy V. Cytomegalovirus-induced Haemophagocytic Lymphohistiocytosis syndrome. BMJ Case Rep 2012. 10.1136/bcr.10.2011.4963</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr.10.2011.4963</ArticleId><ArticleId IdType="pmc">PMC3279657</ArticleId><ArticleId IdType="pubmed">22665909</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang N-H, Lien L-M, Chen W-H. Macrophage activation syndrome in a case of myasthenia gravis with concurrent cytomegalovirus infection. Acta Neurol Taiwan 2020;29:114&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34018170</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohara MM, Blum RN. Cytomegalovirus Ileitis and Hemophagocytic Syndrome Associated with Use of Anti--Tumor Necrosis Factor-- Antibody. Clinical Infectious Diseases 2006;42:733&#x2013;4. 10.1086/500262</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/500262</ArticleId><ArticleId IdType="pubmed">16447129</ArticleId></ArticleIdList></Reference><Reference><Citation>Vakkalagadda CV, Cadena-Semanate R, Non LR. Cytomegalovirus-Associated hemophagocytic syndrome in a 59-year-old woman with ulcerative colitis. Am J Med 2017;130:e305&#x2013;6. 10.1016/j.amjmed.2017.02.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2017.02.018</ArticleId><ArticleId IdType="pubmed">28344134</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockbain BC, Mora Peris B, Abbara A, et al. . Disseminated CMV infection and HLH in a patient with well-controlled HIV and ulcerative colitis. BMJ Case Rep 2019;12:e227916. 10.1136/bcr-2018-227916</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2018-227916</ArticleId><ArticleId IdType="pmc">PMC6381943</ArticleId><ArticleId IdType="pubmed">30755430</ArticleId></ArticleIdList></Reference><Reference><Citation>Aslan B, Erbasan F, &#xd6;&#x11f;&#xfc;t TS, et al. . Macrophage activation syndrome triggered by cytomegalovirus in a patient with granulomatosis with polyangiitis. Rheumatology 2022;61:e72&#x2013;4. 10.1093/rheumatology/keab778</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab778</ArticleId><ArticleId IdType="pubmed">34677572</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel T, Bonnet DPA, Leport J, et al. . Hemophagocytic syndrome in the course of Crohn&#x2019;s disease: possible association with cytomegalovirus infection. Am J Gastroenterol 2009;104:252. 10.1038/ajg.2008.24</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2008.24</ArticleId><ArticleId IdType="pubmed">19098887</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>